Medical Care

Global Renal Denervation Treatment Market Research Report 2024

Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension. 

The global Renal Denervation Treatment market was valued at US$ 511 million in 2023 and is anticipated to reach US$ 718.3 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Renal Denervation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Denervation Treatment.

Report Scope

The Renal Denervation Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Denervation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Renal Denervation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Abbott

ReCor Medical

Boston Scientific

Cardiosonic

Medtronic

Kona medical

Mercator Medsystems

Terumo Corporation

Abbott Laboratories

Theragenics Corporation

Segment by Type

Radiofrequency

Ultrasound

Segment by Application

Hospitals

Ambulatory Surgical Centers

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Renal Denervation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Renal Denervation Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Radiofrequency

1.2.3 Ultrasound

1.3 Market by Application

1.3.1 Global Renal Denervation Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Renal Denervation Treatment Market Perspective (2019-2030)

2.2 Renal Denervation Treatment Growth Trends by Region

2.2.1 Global Renal Denervation Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Renal Denervation Treatment Historic Market Size by Region (2019-2024)

2.2.3 Renal Denervation Treatment Forecasted Market Size by Region (2025-2030)

2.3 Renal Denervation Treatment Market Dynamics

2.3.1 Renal Denervation Treatment Industry Trends

2.3.2 Renal Denervation Treatment Market Drivers

2.3.3 Renal Denervation Treatment Market Challenges

2.3.4 Renal Denervation Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Renal Denervation Treatment Players by Revenue

3.1.1 Global Top Renal Denervation Treatment Players by Revenue (2019-2024)

3.1.2 Global Renal Denervation Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Renal Denervation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Renal Denervation Treatment Revenue

3.4 Global Renal Denervation Treatment Market Concentration Ratio

3.4.1 Global Renal Denervation Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Renal Denervation Treatment Revenue in 2023

3.5 Renal Denervation Treatment Key Players Head office and Area Served

3.6 Key Players Renal Denervation Treatment Product Solution and Service

3.7 Date of Enter into Renal Denervation Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Denervation Treatment Breakdown Data by Type

4.1 Global Renal Denervation Treatment Historic Market Size by Type (2019-2024)

4.2 Global Renal Denervation Treatment Forecasted Market Size by Type (2025-2030)

5 Renal Denervation Treatment Breakdown Data by Application

5.1 Global Renal Denervation Treatment Historic Market Size by Application (2019-2024)

5.2 Global Renal Denervation Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Renal Denervation Treatment Market Size (2019-2030)

6.2 North America Renal Denervation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Renal Denervation Treatment Market Size by Country (2019-2024)

6.4 North America Renal Denervation Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Renal Denervation Treatment Market Size (2019-2030)

7.2 Europe Renal Denervation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Renal Denervation Treatment Market Size by Country (2019-2024)

7.4 Europe Renal Denervation Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Renal Denervation Treatment Market Size (2019-2030)

8.2 Asia-Pacific Renal Denervation Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Renal Denervation Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Renal Denervation Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Renal Denervation Treatment Market Size (2019-2030)

9.2 Latin America Renal Denervation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Renal Denervation Treatment Market Size by Country (2019-2024)

9.4 Latin America Renal Denervation Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Renal Denervation Treatment Market Size (2019-2030)

10.2 Middle East & Africa Renal Denervation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Renal Denervation Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Renal Denervation Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Renal Denervation Treatment Introduction

11.1.4 Abbott Revenue in Renal Denervation Treatment Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 ReCor Medical

11.2.1 ReCor Medical Company Detail

11.2.2 ReCor Medical Business Overview

11.2.3 ReCor Medical Renal Denervation Treatment Introduction

11.2.4 ReCor Medical Revenue in Renal Denervation Treatment Business (2019-2024)

11.2.5 ReCor Medical Recent Development

11.3 Boston Scientific

11.3.1 Boston Scientific Company Detail

11.3.2 Boston Scientific Business Overview

11.3.3 Boston Scientific Renal Denervation Treatment Introduction

11.3.4 Boston Scientific Revenue in Renal Denervation Treatment Business (2019-2024)

11.3.5 Boston Scientific Recent Development

11.4 Cardiosonic

11.4.1 Cardiosonic Company Detail

11.4.2 Cardiosonic Business Overview

11.4.3 Cardiosonic Renal Denervation Treatment Introduction

11.4.4 Cardiosonic Revenue in Renal Denervation Treatment Business (2019-2024)

11.4.5 Cardiosonic Recent Development

11.5 Medtronic

11.5.1 Medtronic Company Detail

11.5.2 Medtronic Business Overview

11.5.3 Medtronic Renal Denervation Treatment Introduction

11.5.4 Medtronic Revenue in Renal Denervation Treatment Business (2019-2024)

11.5.5 Medtronic Recent Development

11.6 Kona medical

11.6.1 Kona medical Company Detail

11.6.2 Kona medical Business Overview

11.6.3 Kona medical Renal Denervation Treatment Introduction

11.6.4 Kona medical Revenue in Renal Denervation Treatment Business (2019-2024)

11.6.5 Kona medical Recent Development

11.7 Mercator Medsystems

11.7.1 Mercator Medsystems Company Detail

11.7.2 Mercator Medsystems Business Overview

11.7.3 Mercator Medsystems Renal Denervation Treatment Introduction

11.7.4 Mercator Medsystems Revenue in Renal Denervation Treatment Business (2019-2024)

11.7.5 Mercator Medsystems Recent Development

11.8 Terumo Corporation

11.8.1 Terumo Corporation Company Detail

11.8.2 Terumo Corporation Business Overview

11.8.3 Terumo Corporation Renal Denervation Treatment Introduction

11.8.4 Terumo Corporation Revenue in Renal Denervation Treatment Business (2019-2024)

11.8.5 Terumo Corporation Recent Development

11.9 Abbott Laboratories

11.9.1 Abbott Laboratories Company Detail

11.9.2 Abbott Laboratories Business Overview

11.9.3 Abbott Laboratories Renal Denervation Treatment Introduction

11.9.4 Abbott Laboratories Revenue in Renal Denervation Treatment Business (2019-2024)

11.9.5 Abbott Laboratories Recent Development

11.10 Theragenics Corporation

11.10.1 Theragenics Corporation Company Detail

11.10.2 Theragenics Corporation Business Overview

11.10.3 Theragenics Corporation Renal Denervation Treatment Introduction

11.10.4 Theragenics Corporation Revenue in Renal Denervation Treatment Business (2019-2024)

11.10.5 Theragenics Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Renal Denervation Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Radiofrequency

Table 3. Key Players of Ultrasound

Table 4. Global Renal Denervation Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Renal Denervation Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Renal Denervation Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Renal Denervation Treatment Market Share by Region (2019-2024)

Table 8. Global Renal Denervation Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Renal Denervation Treatment Market Share by Region (2025-2030)

Table 10. Renal Denervation Treatment Market Trends

Table 11. Renal Denervation Treatment Market Drivers

Table 12. Renal Denervation Treatment Market Challenges

Table 13. Renal Denervation Treatment Market Restraints

Table 14. Global Renal Denervation Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Renal Denervation Treatment Market Share by Players (2019-2024)

Table 16. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2023)

Table 17. Ranking of Global Top Renal Denervation Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Renal Denervation Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Renal Denervation Treatment Product Solution and Service

Table 21. Date of Enter into Renal Denervation Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Renal Denervation Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Renal Denervation Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Renal Denervation Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Renal Denervation Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Renal Denervation Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Renal Denervation Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Renal Denervation Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Renal Denervation Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Renal Denervation Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Renal Denervation Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Renal Denervation Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Renal Denervation Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Renal Denervation Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Renal Denervation Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Renal Denervation Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Renal Denervation Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Renal Denervation Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Renal Denervation Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Renal Denervation Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Renal Denervation Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Abbott Company Detail

Table 47. Abbott Business Overview

Table 48. Abbott Renal Denervation Treatment Product

Table 49. Abbott Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. ReCor Medical Company Detail

Table 52. ReCor Medical Business Overview

Table 53. ReCor Medical Renal Denervation Treatment Product

Table 54. ReCor Medical Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 55. ReCor Medical Recent Development

Table 56. Boston Scientific Company Detail

Table 57. Boston Scientific Business Overview

Table 58. Boston Scientific Renal Denervation Treatment Product

Table 59. Boston Scientific Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 60. Boston Scientific Recent Development

Table 61. Cardiosonic Company Detail

Table 62. Cardiosonic Business Overview

Table 63. Cardiosonic Renal Denervation Treatment Product

Table 64. Cardiosonic Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 65. Cardiosonic Recent Development

Table 66. Medtronic Company Detail

Table 67. Medtronic Business Overview

Table 68. Medtronic Renal Denervation Treatment Product

Table 69. Medtronic Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 70. Medtronic Recent Development

Table 71. Kona medical Company Detail

Table 72. Kona medical Business Overview

Table 73. Kona medical Renal Denervation Treatment Product

Table 74. Kona medical Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 75. Kona medical Recent Development

Table 76. Mercator Medsystems Company Detail

Table 77. Mercator Medsystems Business Overview

Table 78. Mercator Medsystems Renal Denervation Treatment Product

Table 79. Mercator Medsystems Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 80. Mercator Medsystems Recent Development

Table 81. Terumo Corporation Company Detail

Table 82. Terumo Corporation Business Overview

Table 83. Terumo Corporation Renal Denervation Treatment Product

Table 84. Terumo Corporation Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 85. Terumo Corporation Recent Development

Table 86. Abbott Laboratories Company Detail

Table 87. Abbott Laboratories Business Overview

Table 88. Abbott Laboratories Renal Denervation Treatment Product

Table 89. Abbott Laboratories Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 90. Abbott Laboratories Recent Development

Table 91. Theragenics Corporation Company Detail

Table 92. Theragenics Corporation Business Overview

Table 93. Theragenics Corporation Renal Denervation Treatment Product

Table 94. Theragenics Corporation Revenue in Renal Denervation Treatment Business (2019-2024) & (US$ Million)

Table 95. Theragenics Corporation Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Renal Denervation Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Renal Denervation Treatment Market Share by Type: 2023 VS 2030

Figure 3. Radiofrequency Features

Figure 4. Ultrasound Features

Figure 5. Global Renal Denervation Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Renal Denervation Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Ambulatory Surgical Centers Case Studies

Figure 9. Others Case Studies

Figure 10. Renal Denervation Treatment Report Years Considered

Figure 11. Global Renal Denervation Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Renal Denervation Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Renal Denervation Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Renal Denervation Treatment Market Share by Players in 2023

Figure 15. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Renal Denervation Treatment Revenue in 2023

Figure 17. North America Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Renal Denervation Treatment Market Share by Country (2019-2030)

Figure 19. United States Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Renal Denervation Treatment Market Share by Country (2019-2030)

Figure 23. Germany Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Renal Denervation Treatment Market Share by Region (2019-2030)

Figure 31. China Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Renal Denervation Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Renal Denervation Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Renal Denervation Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Abbott Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 46. ReCor Medical Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 47. Boston Scientific Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 48. Cardiosonic Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 49. Medtronic Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 50. Kona medical Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 51. Mercator Medsystems Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 52. Terumo Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 53. Abbott Laboratories Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 54. Theragenics Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies